Today: 8 February 2026
Subscribe

Corcept Therapeutics stock tanks 50% after FDA relacorilant setback — what’s next for CORT

Corcept Therapeutics stock tanks 50% after FDA relacorilant setback — what’s next for CORT

Corcept Therapeutics shares fell 50.4% to $34.80 after the FDA declined to approve relacorilant for Cushing’s-related hypertension, citing a need for more evidence of effectiveness. The company plans to meet with the agency to discuss next steps. Wolfe Research downgraded the stock and removed projected sales for the indication. Trading volume reached about 20.16 million shares.
1 January 2026
··
Axsome stock jumps 23% after FDA sets April 30 deadline for Alzheimer’s agitation review

Axsome stock jumps 23% after FDA sets April 30 deadline for Alzheimer’s agitation review

Axsome Therapeutics shares surged 22.9% to $182.64 after the FDA granted priority review to its application for AXS-05 in treating agitation in Alzheimer’s disease, setting an April 30 decision date. The company also plans to file for approval of AXS-12 for cataplexy in narcolepsy this month, following supportive FDA meeting minutes. Trading volume reached 3.1 million shares.
1 January 2026
··
INBS stock whipsaws after Intelligent Bio Solutions lines up $10 million funding

INBS stock whipsaws after Intelligent Bio Solutions lines up $10 million funding

Intelligent Bio Solutions shares jumped 132% to $9.53 before dropping 14% after-hours as the company announced a $10 million private placement and a new manufacturing deal with Syrma Johari MedTech. The placement, priced at $4.35 per share and warrants, is set well below the closing price. Volume hit 108 million shares. The company recently enacted a 1-for-10 reverse split after a Nasdaq minimum bid warning.
1 January 2026
··
Nike stock jumps on CEO’s $1 million buy — what NKE investors watch next

Nike stock jumps on CEO’s $1 million buy — what NKE investors watch next

Nike shares rose 4.1% to $63.71 in the final 2025 session after CEO Elliott Hill bought 16,388 shares for about $1 million, according to an SEC filing. The gain came as Wall Street closed the year lower and Under Armour shares fell 3%. Trading volumes were thin ahead of the New Year’s Day market holiday. Investors are watching for updates on Nike’s margins and China demand as earnings approach.
1 January 2026
·
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 01.01.2026

E to E Transportation Infrastructure listed on NSE SME at ₹330.60, nearly 90% above its ₹174 IPO price after seeing 526.56 times oversubscription. British American Tobacco Malaysia’s parent holds 50% of shares, with individuals at 32%. Uni-Asia Group posted a 96% five-year TSR despite a 14% annual revenue decline. Nifty50 opened at 26,172.90 and Sensex gained about 100 points.
1 January 2026
··
Applied Materials stock drops again as China’s “50% local tools” push weighs on AMAT

Applied Materials stock drops again as China’s “50% local tools” push weighs on AMAT

Applied Materials shares fell 1.1% to $256.99 Wednesday, extending a two-day slide as China moved to require chipmakers to use at least 50% domestic equipment for new semiconductor plants, Reuters reported. Lam Research dropped 1.5% and KLA lost 2.3%. TSMC said it received a U.S. export license for its Nanjing fab, allowing continued equipment shipments. Trading in Applied was light, with the stock closing about 7% below its recent high.
1 January 2026
····
Marvell (MRVL) stock drops 2% into year-end close as chip trade cools — what’s next

Marvell (MRVL) stock drops 2% into year-end close as chip trade cools — what’s next

Marvell Technology shares fell 2.1% to $84.98 Wednesday on volume of 7.2 million as the Nasdaq and S&P 500 closed lower in thin year-end trading. Marvell’s $3.25 billion Celestial AI acquisition is expected to close in Q1 2026, per SEC filings. CEO Matt Murphy projects $10 billion in fiscal-year revenue, with data center sales up 25%. U.S. markets close Thursday for New Year’s and reopen Friday.
1 January 2026
··
Caterpillar stock ends 2025 lower — what investors are watching for CAT in January

Caterpillar stock ends 2025 lower — what investors are watching for CAT in January

NEW YORK, December 31, 2025, 21:11 ET — Market closed Caterpillar Inc shares slipped about 0.8% on Wednesday to close at $572.87, as U.S. stocks ended the year’s final session lower. MarketWatch+1 The move matters because Caterpillar is widely treated as a read-through on capital spending, from construction equipment to mining and energy projects. With 2026 starting amid shifting rate expectations and trade uncertainty, investors are using late-year price action as a quick gauge of risk appetite. Reuters Caterpillar is also coming off a strong 2025 run, leaving the stock more sensitive to profit-taking and any reset in expectations around
1 January 2026
·
GE Aerospace stock slips into year-end close — what investors watch next

GE Aerospace stock slips into year-end close — what investors watch next

NEW YORK, December 31, 2025, 20:50 ET — Market closed GE Aerospace shares closed down 1.2% on Wednesday at $308.03, trimming year-end gains after a strong run through 2025. The stock still ended the year up about 85%, based on its Dec. 31, 2024 close of $166.79. Chase ID Center The late-year dip matters because GE has been one of the market’s standout industrial winners, leaving less room for disappointment as investors reset portfolios for 2026. Traders are using the last prints of the year to gauge whether aerospace leaders can hold premium valuations into a January stretch packed with
1 January 2026
··
Lam Research stock slips into year-end close — what traders watch next for LRCX

Lam Research stock slips into year-end close — what traders watch next for LRCX

NEW YORK, December 31, 2025, 20:53 ET — Market closed Lam Research Corp shares fell 1.5% to $171.18 on Wednesday, extending a three-session slide as the chip equipment maker closed out the final trading day of 2025. MarketWatch The decline came as Wall Street finished the year with modest losses in thin holiday trading, with the S&P 500 down 0.74% and the Nasdaq off 0.76%, Reuters reported. Reuters That matters now because Lam is a bellwether for wafer fabrication equipment — the costly chipmaking tools used to build semiconductors — and positioning into 2026 is being driven by expectations for
1 January 2026
Mastercard stock ends 2025 lower as Wall Street slips — what’s next for MA shares

Mastercard stock ends 2025 lower as Wall Street slips — what’s next for MA shares

NEW YORK, December 31, 2025, 20:52 ET — Market closed Mastercard Incorporated shares fell 1.13% on Wednesday to close at $570.88, after trading between $570.79 and $578.00. The late-year dip matters because investors often treat card networks like Mastercard as read-throughs on consumer and business spending, especially into the first data-heavy weeks of a new year. It also lands at a moment when portfolio managers are resetting risk after a strong 2025, with interest-rate expectations and economic momentum likely to steer early-2026 positioning. Wall Street’s main indexes ended 2025 lower in holiday-thin trading, with the S&P 500 down 0.74%, and
1 January 2026
·
1 … 639 640 641 642 643 … 1,641

Stock Market Today

RELX share price slides again on AI worries; what to watch ahead of Feb 12 results

RELX share price slides again on AI worries; what to watch ahead of Feb 12 results

8 February 2026
RELX shares fell 4.6% to 2,145p on Friday, near a 52-week low, despite the FTSE 100 closing higher. The company disclosed a new buyback of 465,361 shares on Feb. 6 and has repurchased over 8.8 million shares since Jan. 2. Investors await RELX’s full-year 2025 results on Feb. 12 amid concerns over AI’s impact on its core business.
Glencore shares steady after Rio walks away — what to watch before Monday’s trade

Glencore shares steady after Rio walks away — what to watch before Monday’s trade

8 February 2026
Glencore shares closed up 0.6% at 478.10 pence Friday after Rio Tinto ended merger talks, issuing a “no intention to bid” statement. Glencore’s board rejected the proposed deal terms, citing concerns over valuation and governance. Attention now turns to possible asset sales, including its $5 billion Kazzinc stake, ahead of Glencore’s annual results on Feb. 18.
Go toTop